{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:05:34Z","timestamp":1791576334504,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["667302"],"award-info":[{"award-number":["667302"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["667302"],"award-info":[{"award-number":["667302"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["667302"],"award-info":[{"award-number":["667302"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["667302"],"award-info":[{"award-number":["667302"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["445498183"],"award-info":[{"award-number":["445498183"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent GWAS allow us to calculate polygenic risk scores for ADHD. At the imaging level, resting-state fMRI analyses have given us valuable insights into changes in connectivity patterns in ADHD patients. However, no study has yet attempted to combine these two different levels of investigation. For this endeavor, we used a dopaminergic challenge fMRI study (L-DOPA) in healthy participants who were genotyped for their ADHD, MDD, schizophrenia, and body height polygenic risk score (PRS) and compared results with a study comparing ADHD patients and healthy controls. Our objective was to evaluate how L-DOPA-induced changes of reward-system-related FC are dependent on the individual polygenic risk score. FMRI imaging was used to evaluate resting-state functional connectivity (FC) of targeted subcortical structures in 27 ADHD patients and matched controls. In a second study, we evaluated the effect of ADHD and non-ADHD PRS in a L-DOPA-based pharmaco-fMRI-challenge in 34 healthy volunteers. The functional connectivity between the putamen and parietal lobe was decreased in ADHD patients. In healthy volunteers, the FC between putamen and parietal lobe was lower in ADHD high genetic risk participants. This direction of connectivity was reversed during L-DOPA challenge. Further findings are described for other dopaminergic subcortical structures. The FC between the putamen and the attention network showed the most consistent change in patients as well as in high-risk participants. Our results suggest that FC of the dorsal attention network is altered in adult ADHD as well as in healthy controls with higher genetic risk.<\/jats:p>","DOI":"10.1038\/s41398-022-02003-y","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T07:07:45Z","timestamp":1656486465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is genetic risk of ADHD mediated via dopaminergic mechanism? A study of functional connectivity in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-0301","authenticated-orcid":false,"given":"Oliver","family":"Grimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Thom\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten M.","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-634X","authenticated-orcid":false,"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"2003_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41380-018-0070-0","volume":"24","author":"SV Faraone","year":"2019","unstructured":"Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24:562\u201375.","journal-title":"Mol Psychiatry"},{"key":"2003_CR2","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41386-020-0664-5","volume":"45","author":"P Rovira","year":"2020","unstructured":"Rovira P, Demontis D, S\u00e1nchez-Mora C, Zayats T, Klein M, Mota NR, et al. Shared genetic background between children and adults with attention deficit\/hyperactivity disorder. Neuropsychopharmacology. 2020;45:1617\u201326.","journal-title":"Neuropsychopharmacology"},{"key":"2003_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"D Demontis","year":"2019","unstructured":"Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder. Nat Genet. 2019;51:63\u201375.","journal-title":"Nat Genet"},{"key":"2003_CR4","doi-asserted-by":"publisher","unstructured":"Sudre G, Sharp W, Kundzicz P, Bouyssi-Kobar M, Norman L, Choudhury S, et al. Predicting the course of ADHD symptoms through the integration of childhood genomic, neural, and cognitive features. Mol Psychiatry 2020. https:\/\/doi.org\/10.1038\/s41380-020-00941-x.","DOI":"10.1038\/s41380-020-00941-x"},{"key":"2003_CR5","doi-asserted-by":"publisher","unstructured":"Grimm O, Weber H, Kittel-Schneider S, Kranz TM, Jacob CP, Lesch KP, et al. Impulsivity and venturesomeness in an adult ADHD sample: relation to personality, comorbidity, and polygenic risk. Front. Psychiatry. 2020. https:\/\/doi.org\/10.3389\/fpsyt.2020.557160.","DOI":"10.3389\/fpsyt.2020.557160"},{"key":"2003_CR6","doi-asserted-by":"publisher","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018. https:\/\/doi.org\/10.1016\/S2215-0366(18)30269-4.","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"2003_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","volume":"87","author":"SV Faraone","year":"2018","unstructured":"Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255\u201370.","journal-title":"Neurosci Biobehav Rev"},{"key":"2003_CR8","doi-asserted-by":"publisher","unstructured":"Grimm O, Kranz TM, Reif A. Genetics of ADHD: what should the clinician know? Curr. Psychiatry Rep. 2020. https:\/\/doi.org\/10.1007\/s11920-020-1141-x.","DOI":"10.1007\/s11920-020-1141-x"},{"key":"2003_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.neuron.2010.11.022","volume":"68","author":"ES Bromberg-Martin","year":"2010","unstructured":"Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron. 2010;68:815\u201334.","journal-title":"Neuron"},{"key":"2003_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuroimage.2017.07.042","volume":"159","author":"P Smittenaar","year":"2017","unstructured":"Smittenaar P, Kurth-Nelson Z, Mohammadi S, Weiskopf N, Dolan RJ. Local striatal reward signals can be predicted from corticostriatal connectivity. Neuroimage. 2017;159:9\u201317.","journal-title":"Neuroimage"},{"key":"2003_CR11","doi-asserted-by":"publisher","unstructured":"Posner J, Rauh V, Gruber A, Gat I, Wang Z, Peterson BS. Dissociable attentional and affective circuits in medication-na\u00efve children with attention-deficit\/hyperactivity disorder. Psychiatry Res. Neuroimaging. 2013. https:\/\/doi.org\/10.1016\/j.pscychresns.2013.01.004.","DOI":"10.1016\/j.pscychresns.2013.01.004"},{"key":"2003_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopsych.2011.11.003","volume":"71","author":"D Tomasi","year":"2012","unstructured":"Tomasi D, Volkow ND. Abnormal functional connectivity in children with attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2012;71:443\u201350.","journal-title":"Biol Psychiatry"},{"key":"2003_CR13","doi-asserted-by":"publisher","unstructured":"Costa Dias TG, Wilson VB, Bathula DR, Iyer SP, Mills KL, Thurlow BL, et al. Reward circuit connectivity relates to delay discounting in children with attention-deficit\/hyperactivity disorder. Eur Neuropsychopharmacol. 2013. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.015.","DOI":"10.1016\/j.euroneuro.2012.10.015"},{"key":"2003_CR14","first-page":"353","volume":"1","author":"M Oldehinkel","year":"2016","unstructured":"Oldehinkel M, Beckmann CF, Pruim RHR, van Oort ESB, Franke B, Hartman CA, et al. Attention-deficit\/hyperactivity disorder symptoms coincide with altered striatal connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:353\u201363.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2003_CR15","doi-asserted-by":"publisher","unstructured":"Barber AD, Sarpal DK, John M, Fales CL, Mostofsky SH, Malhotra AK, et al. Age-normative pathways of striatal connectivity related to clinical symptoms in the general population. Biol Psychiatry. 2019. https:\/\/doi.org\/10.1016\/j.biopsych.2019.01.024.","DOI":"10.1016\/j.biopsych.2019.01.024"},{"key":"2003_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41398-021-01758-0","volume":"11","author":"O Grimm","year":"2021","unstructured":"Grimm O. et al. Effects of comorbid disorders on reward processing and connectivity in adults with ADHD. Transl Psychiat. 2021;11:636.","journal-title":"Transl Psychiat"},{"key":"2003_CR17","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/hbm.24913","volume":"41","author":"O Grimm","year":"2020","unstructured":"Grimm O, Kopfer V, K\u00fcpper\u2010Tetzel L, Deppert V, Kuhn M, Greck M, et al. Amisulpride and l\u2010DOPA modulate subcortical brain nuclei connectivity in resting\u2010state pharmacologic magnetic resonance imaging. Hum Brain Mapp. 2020;41:1806\u201318.","journal-title":"Hum Brain Mapp"},{"key":"2003_CR18","doi-asserted-by":"publisher","unstructured":"Ikemoto S, Yang C, Tan A. Basal ganglia circuit loops, dopamine and motivation: a review and enquiry. Behav Brain Res. 2015. https:\/\/doi.org\/10.1016\/j.bbr.2015.04.018.","DOI":"10.1016\/j.bbr.2015.04.018"},{"key":"2003_CR19","first-page":"1123","volume":"5","author":"NP Jones","year":"2020","unstructured":"Jones NP, Versace A, Lindstrom R, Wilson TK, Gnagy EM, Pelham WE, et al. Reduced activation in the pallidal-thalamic-motor pathway is associated with deficits in reward-modulated inhibitory control in adults with a history of attention-deficit\/hyperactivity disorder. Biol Psychiatry: Cogn Neurosci Neuroimaging. 2020;5:1123\u201333.","journal-title":"Biol Psychiatry: Cogn Neurosci Neuroimaging"},{"key":"2003_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0304-3940(99)00840-X","volume":"277","author":"JA Ihalainen","year":"1999","unstructured":"Ihalainen JA, Riekkinen P Jr, Feenstra MGP. Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysis. Neurosci Lett. 1999;277:71\u201374.","journal-title":"Neurosci Lett"},{"key":"2003_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01245342","volume":"93","author":"JJ Chrobak","year":"1993","unstructured":"Chrobak JJ, Napier TC. Opioid and GABA modulation of accumbens-evoked ventral pallidal activity. J Neural Transm Gen Sect. 1993;93:123\u201343.","journal-title":"J Neural Transm Gen Sect"},{"key":"2003_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41386-019-0592-4","volume":"45","author":"NR Mota","year":"2020","unstructured":"Mota NR, Poelmans G, Klein M, Torrico B, Fern\u00e0ndez-Castillo N, Cormand B, et al. Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between attention-deficit\/hyperactivity disorder and obesity measures. Neuropsychopharmacology. 2020;45:1188\u201395.","journal-title":"Neuropsychopharmacology"},{"key":"2003_CR23","doi-asserted-by":"publisher","unstructured":"Choi EY, Thomas Yeo BT, Buckner RL. The organization of the human striatum estimated by intrinsic functional connectivity. J Neurophysiol. 2012. https:\/\/doi.org\/10.1152\/jn.00270.2012.","DOI":"10.1152\/jn.00270.2012"},{"key":"2003_CR24","doi-asserted-by":"publisher","unstructured":"Peters AJ, Fabre JMJ, Steinmetz NA, Harris KD, Carandini M. Striatal activity topographically reflects cortical activity. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-020-03166-8.","DOI":"10.1038\/s41586-020-03166-8"},{"key":"2003_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"2003_CR26","doi-asserted-by":"publisher","unstructured":"Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014. https:\/\/doi.org\/10.1038\/ng.3097.","DOI":"10.1038\/ng.3097"},{"key":"2003_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S1053-8119(03)00073-9","volume":"19","author":"R Deichmann","year":"2003","unstructured":"Deichmann R, Gottfried JA, Hutton C, Turner R. Optimized EPI for fMRI studies of the orbitofrontal cortex. Neuroimage. 2003;19:430\u201341.","journal-title":"Neuroimage"},{"key":"2003_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.63","volume":"5","author":"WM Pauli","year":"2018","unstructured":"Pauli WM, Nili AN, Tyszka JM. A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei. Sci Data. 2018;5:180063.","journal-title":"Sci Data"},{"key":"2003_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"2003_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity. 2012;2:125\u201341.","journal-title":"Brain Connectivity"},{"key":"2003_CR31","doi-asserted-by":"publisher","unstructured":"Grimm O, L\u00f6ffler M, Kamping S, Hartmann A, Rohleder C, Leweke M, et al. Probing the endocannabinoid system in healthy volunteers: cannabidiol alters fronto-striatal resting-state connectivity. Eur Neuropsychopharmacol. 2018. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.04.004.","DOI":"10.1016\/j.euroneuro.2018.04.004"},{"key":"2003_CR32","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.1073\/pnas.0604187103","volume":"103","author":"MD Fox","year":"2006","unstructured":"Fox MD, Corbetta M, Snyder AZ, Vincent JL, Raichle ME. Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems. Proc Natl Acad Sci USA. 2006;103:10046\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2003_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1176\/appi.ajp.2012.11101521","volume":"169","author":"S Cortese","year":"2012","unstructured":"Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI sudies. Am J Psychiatry. 2012;169:1038\u201355.","journal-title":"Am J Psychiatry"},{"key":"2003_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopsych.2011.11.003","volume":"71","author":"D Tomasi","year":"2012","unstructured":"Tomasi D, Volkow ND. Abnormal functional connectivity in children with attention-deficit\/ hyperactivity disorder. Biol Psychiatry. 2012;71:443\u201350.","journal-title":"Biol Psychiatry"},{"key":"2003_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/jcpp.12529","volume":"57","author":"D Von Rhein","year":"2016","unstructured":"Von Rhein D, Oldehinkel M, Beckmann CF, Oosterlaan J, Heslenfeld D, Hartman CA, et al. Aberrant local striatal functional connectivity in attention-deficit\/hyperactivity disorder. J Child Psychol Psychiatry Allied Discip. 2016;57:697\u2013705.","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"key":"2003_CR36","doi-asserted-by":"publisher","unstructured":"Gallo EF, Meszaros J, Sherman JD, Chohan MO, Teboul E, Choi CS, et al. Accumbens dopamine D2 receptors increase motivation by decreasing inhibitory transmission to the ventral pallidum. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-03272-2.","DOI":"10.1038\/s41467-018-03272-2"},{"key":"2003_CR37","doi-asserted-by":"publisher","unstructured":"McLeod KR, Langevin LM, Goodyear BG, Dewey D. Functional connectivity of neural motor networks is disrupted in children with developmental coordination disorder and attention-deficit\/hyperactivity disorder. NeuroImage: Clin. 2014. https:\/\/doi.org\/10.1016\/j.nicl.2014.03.010.","DOI":"10.1016\/j.nicl.2014.03.010"},{"key":"2003_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cortex.2011.04.007","volume":"48","author":"A Cubillo","year":"2012","unstructured":"Cubillo A, Halari R, Smith A, Taylor E, Rubia K. A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with attention deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex. 2012;48:194\u2013215.","journal-title":"Cortex"},{"key":"2003_CR39","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1017\/S003329171900237X","volume":"49","author":"Y Gao","year":"2019","unstructured":"Gao Y, Shuai D, Bu X, Hu X, Tang S, Zhang L, et al. Impairments of large-scale functional networks in attention-deficit\/hyperactivity disorder: a meta-analysis of resting-state functional connectivity. Psychological Med. 2019;49:2475\u201385.","journal-title":"Psychological Med"},{"key":"2003_CR40","doi-asserted-by":"publisher","unstructured":"Martins D, Mehta MA, Prata D. The \u201chighs and lows\u201d of the human brain on dopaminergics: evidence from neuropharmacology. Neurosci Biobehav Rev. 2017. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.06.003.","DOI":"10.1016\/j.neubiorev.2017.06.003"},{"key":"2003_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn3475","volume":"14","author":"KS Button","year":"2013","unstructured":"Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14:365\u201376.","journal-title":"Nat Rev Neurosci"},{"key":"2003_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30:228\u201335.","journal-title":"Trends Neurosci"},{"key":"2003_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12450-9","volume":"10","author":"C Liao","year":"2019","unstructured":"Liao C, Laporte AD, Spiegelman D, Ak\u00e7imen F, Joober R, Dion PA, et al. Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes. Nat Commun. 2019;10:1\u20137.","journal-title":"Nat Commun"},{"key":"2003_CR44","doi-asserted-by":"publisher","first-page":"5131 LP","DOI":"10.1523\/JNEUROSCI.1021-04.2004","volume":"24","author":"KY Tseng","year":"2004","unstructured":"Tseng KY, Donnell P. Dopamine\u2013glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci. 2004;24:5131 LP\u20135139.","journal-title":"J Neurosci"},{"key":"2003_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnint.2019.00020","volume":"13","author":"L van der Velden","year":"2019","unstructured":"van der Velden L, Vinck MA, Werkman TR, Wadman WJ. Modulation of functional connectivity between dopamine neurons of the rat ventral tegmental area in vitro. Front Integr Neurosci. 2019;13:20.","journal-title":"Front Integr Neurosci"},{"key":"2003_CR46","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41380-018-0210-6","volume":"25","author":"J Corominas","year":"2020","unstructured":"Corominas J, Klein M, Zayats T, Rivero O, Ziegler GC, Pauper M, et al. Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing. Mol Psychiatry. 2020;25:2047\u201357.","journal-title":"Mol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02003-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:42:46Z","timestamp":1669214566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02003-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2003"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02003-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Dr. Andreas Reif received personal fees from MEDICE Arzneimittel P\u00fctter GmbH & Co. KG, Shire PLC, neuraxpharm Arzneimittel GmbH, Janssen-Cilag GmbH and Servier Deutschland GmbH present or during 36 months prior to publication. Oliver Grimm received personal fees from MEDICE Arzneimittel P\u00fctter GmbH & Co. KG. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}